Search for: "Boehringer Ingelheim Corp."
Results 1 - 20
of 53
Sorted by Relevance
|
Sort by Date
5 Apr 2020, 9:57 pm
Plaintiffs-Appellants Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Corp.; and Boehringer Ingelheim... [read post]
28 Mar 2007, 5:25 am
Another little IP gem from online subscription service LexisNexis Butterworths is the Chancery Division for England and Wales decision on Monday of Mr Justice Patten in Boehringer Ingelheim Ltd v Vetplus Ltd, so far unreported on BAILII.This was an application by Boehringer for ex parte interim injunctive relief to stop Vetplus publishing an advertisement and a press release in various journals relating to one of its products. [read post]
22 Oct 2012, 8:28 am
Boehringer Ingelheim Corp. [read post]
13 May 2010, 4:44 pm
The companies, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Roxane Inc., Ben Venue Laboratories Inc. and Roxane Laboratories Inc., are all affiliates of German drug giant, Boehringer Ingelheim GmbH. [read post]
19 Aug 2013, 8:39 am
Boehringer Ingelheim Corp. [read post]
4 Mar 2015, 1:32 pm
Last week, MBBP’s Scott Bleier attended a panel discussion hosted by the Johnson & Johnson Boston Innovation Center, which featured three corporate venture capitalists from Sanofi-Genzyme Bioventures, Boehringer Ingelheim Venture USA Inc. and Johnson & Johnson Development Corp. [read post]
17 Jun 2013, 10:27 am
” Boehringer Ingelheim Vetmedica v. [read post]
25 Jan 2010, 10:39 am
Boehringer Ingelheim Int'l v. [read post]
20 Aug 2012, 11:15 am
Since coming on the market in October 2010 the FDA has received numerous Adverse Event Reports involving: • Serious bleeding side effects • Hemorrhages such as hemorrhagic stroke In addition, some medical studies have associated Pradaxa with an increased risk: • Heart attack • Myocardial infarction (MI)• Acute coronary syndrome (ACS) Due to these serious side effects, a growing number of personal injury and wrongful death Pradaxa lawsuits have been filed against… [read post]
19 Dec 2010, 9:44 am
American NTN Bearing Manufacturing Corp., 495 F.3d 840 (7th Cir. 2007), to his claims. [read post]
23 Jan 2013, 4:16 pm
” Boehringer Ingelheim Vetmedica, Inc. v. [read post]
24 Dec 2013, 5:49 am
” Boehringer Ingelheim Vetmedica, Inc. v. [read post]
28 Jul 2014, 8:38 am
Boehringer Ingelheim Vetmedica, Inc. v. [read post]
25 Jul 2014, 8:04 am
Boehringer Ingelheim Vetmedica, Inc. v. [read post]
13 Mar 2012, 10:10 am
Oral argument argued before the Eighth Circuit U.S. [read post]
29 Aug 2007, 10:22 am
Boehringer Ingelheim Vetmedica, Inc. (17-CA-22964; 350 NLRB No. 60) St. [read post]
17 Jan 2007, 5:24 am
.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime requirements. [read post]
7 Dec 2010, 2:43 am
As for Roxane: Roxane is paying $280 million to resolve claims against it and related entities (Roxane Laboratories Inc., Boehringer Ingelheim Corp. and Boehringer Ingelheim Pharmaceuticals Inc.). [read post]
25 Nov 2012, 1:10 pm
Medik had argued, citing Celanese international Corp v BP Chemicals Ltd [1999] RPC 203, that it was entitled to deduct a portion of general overheads - cost of premises and general staff costs. [read post]
5 May 2010, 4:46 am
– Supreme Court of Justice decision on Viagra patent (IPKat) (IP tango) Further developments on double patenting at the EPO – T1423/07 Cyclic Amine derivative/BOEHRINGER INGELHEIM VETMEDICA GmbH (IPKat) (EPLAW) General BIO announces new policy on options for increasing access to medicines in the developing world (Patently BIOtech) BIO2010 Day 1 & 2: Getting Settled & Meetings & Measuring Biotechnology Innovation (Biotech Blog) (Biotech Blog)… [read post]
